The biology and management of systemic anaplastic large cell lymphoma

G Hapgood, KJ Savage - Blood, The Journal of the American …, 2015 - ashpublications.org
Systemic anaplastic large cell lymphoma (ALCL) is an aggressive CD30+ non-Hodgkin
lymphoma. Anaplastic lymphoma kinase–positive (ALK+) ALCL is associated with the NPM …

CD30+ anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features

H Stein, HD Foss, H Dürkop… - Blood, The Journal …, 2000 - ashpublications.org
Anaplastic large cell lymphoma (ALCL) represents a generally recognized group of large
cell lymphomas. Defining features consist of a proliferation of predominantly large lymphoid …

[图书][B] WHO classification of tumours of haematopoietic and lymphoid tissues

SH Swerdlow, E Campo, NL Harris, ES Jaffe, SA Pileri… - 2008 - hero.epa.gov
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues is the second
volume of the 4th Edition of the WHO series on histological and genetic typing of human …

[HTML][HTML] Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype

B Falini, C Mecucci, E Tiacci, M Alcalay… - … England Journal of …, 2005 - Mass Medical Soc
Background Nucleophosmin (NPM), a nucleocytoplasmic shuttling protein with prominent
nucleolar localization, regulates the ARF-p53 tumor-suppressor pathway. Translocations …

[图书][B] Pathology and genetics of tumours of haematopoietic and lymphoid tissues

ES Jaffe - 2001 - books.google.com
This is the third volume in the new World Health Organization series on histological and
genetic typing of tumours. Tumours of the haematopoietic and lymphoid tissues are covered …

TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors

B Lawrence, A Perez-Atayde, MK Hibbard… - The American journal of …, 2000 - Elsevier
Inflammatory myofibroblastic tumors (IMTs) are neoplastic mesenchymal proliferations
featuring an inflammatory infiltrate composed primarily of lymphocytes and plasma cells. The …

Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features

B Falini, I Nicoletti, MF Martelli, C Mecucci - Blood, 2007 - ashpublications.org
The nucleophosmin (NPM1) gene encodes for a multifunctional nucleocytoplasmic shuttling
protein that is localized mainly in the nucleolus. NPM1 mutations occur in 50% to 60% of …

[PDF][PDF] Epigenetics meets endocrinology

X Zhang, SM Ho - Journal of molecular endocrinology, 2011 - jme.bioscientifica.com
Although genetics determines endocrine phenotypes, it cannot fully explain the great
variability and reversibility of the system in response to environmental changes. Evidence …

EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues

MP Martelli, G Sozzi, L Hernandez, V Pettirossi… - The American journal of …, 2009 - Elsevier
A fusion gene, echinoderm microtubule associated protein like 4–anaplastic lymphoma
kinase (EML4-ALK), with transforming activity has recently been identified in a subset of non …

Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+ AML) shows a distinct gene expression profile characterized by up-regulation of genes involved …

M Alcalay, E Tiacci, R Bergomas, B Bigerna… - Blood, 2005 - ashpublications.org
Approximately one third of acute myeloid leukemias (AMLs) are characterized by aberrant
cytoplasmic localization of nucleophosmin (NPMc+ AML), consequent to mutations in the …